IER3IP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.785000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.022600E-01
Normal-vs-Stage2
7.606000E-01
Normal-vs-Stage3
9.578200E-01
Normal-vs-Stage4
9.992600E-01
Stage1-vs-Stage2
2.384300E-02
Stage1-vs-Stage3
1.519790E-01
Stage1-vs-Stage4
2.003200E-01
Stage2-vs-Stage3
6.793600E-01
Stage2-vs-Stage4
7.292800E-01
Stage3-vs-Stage4
9.658000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.606000E-01
Normal-vs-AfricanAmerican
3.124000E-01
Normal-vs-Asian
3.954800E-01
Caucasian-vs-AfricanAmerican
7.849800E-01
Caucasian-vs-Asian
2.417500E-03
AfricanAmerican-vs-Asian
2.331500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.928400E-01
Normal-vs-Female
5.844200E-01
Male-vs-Female
5.947700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.057200E-01
Normal-vs-Age(41-60Yrs)
5.497000E-01
Normal-vs-Age(61-80Yrs)
7.841200E-01
Normal-vs-Age(81-100Yrs)
7.124600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.109800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.626200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.864200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.161900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.525560E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.335000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.682800E-01
Normal-vs-Daily Drinker
8.294600E-01
Normal-vs-Weekly Drinker
6.709800E-01
Normal-vs-Occasional Drinker
2.977400E-01
Normal-vs-Social Drinker
2.894800E-01
Non Drinker-vs-Daily Drinker
5.520000E-01
Non Drinker-vs-Weekly Drinker
3.510800E-01
Non Drinker-vs-Occasional Drinker
1.783670E-02
Non Drinker-vs-Social Drinker
2.674400E-01
Daily Drinker-vs-Weekly Drinker
6.528800E-01
Daily Drinker-vs-Occasional Drinker
8.869800E-02
Daily Drinker-vs-Social Drinker
3.452200E-01
Weekly Drinker-vs-Occasional Drinker
2.979000E-01
Weekly Drinker-vs-Social Drinker
4.482800E-01
Occasional Drinker-vs-Social Drinker
7.467400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.020800E-01
Normal-vs-Grade 2
8.463800E-01
Normal-vs-Grade 3
8.346200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.264100E-02
Grade 1-vs-Grade 3
7.869700E-02
Grade 1-vs-Grade 4
9.020800E-01
Grade 2-vs-Grade 3
6.869800E-01
Grade 2-vs-Grade 4
8.463800E-01
Grade 3-vs-Grade 4
8.346200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.995800E-01
Normal-vs-NonDiabetic
6.598400E-01
Diabetic-vs-NonDiabetic
3.118100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.962800E-01
Normal-vs-NoPancreatitis
6.947200E-01
Pancreatitis-vs-NoPancreatitis
7.806200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.184800E-01
Normal-vs-N1
7.086000E-01
N0-vs-N1
1.521050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.627000E-01
Normal-vs-TP53-NonMutant
8.578400E-02
TP53-Mutant-vs-TP53-NonMutant
2.548500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
